Defective Drug Blog Posts

Losartan Recall Expanded

Torrent Pharmaceuticals Limited is expanding its voluntary recall for Losartan which is typically used to control high blood pressure (hypertension) nationwide. The Food and Drug Administration (FDA) says some Losartan Potassium Tablets USP and Losartan… Read More

Proton Pump Inhibitors Tied to Higher Risk of Death

A new study has shown that proton pump inhibitors (PPIs), a type of drug commonly used to treat heartburn, can increase a user’s risk of death by 25 percent. The Phillips Law Group’s dedicated Phoenix defective drug attorneys want you to know the risks… Read More

Jury Orders GlaxoSmithKline to Pay $3 Million in Generic Paxil Lawsuit

Drug manufacturer GlaxoSmithKline (GSK) must pay $3 million to a woman after a jury concluded Thursday that her husband’s suicide was linked to a generic version of the antidepressant drug Paxil. The jury reached its verdict after a trial in a Chicago… Read More

Study Reveals Long-Term Use of PPIs Is Linked to Kidney Damage

A recent study has linked proton pump inhibitor (PPIs), medications used to suppress heartburn and acid reflux disease, to increased risk of kidney damage. The five-year study, published in Kidney International, looked at 125,596 patients prescribed… Read More

Levaquin RICO Lawsuit

Pharmaceutical giant Johnson & Johnson faces yet another lawsuit for allegedly concealing harmful and potentially deadly side effects caused by its antibiotic Levaquin. The latest Levaquin lawsuit was filed in the U.S. District Court on Jan. 18, 2016,… Read More

New Analysis of Paxil Study Shows it is Not Safe for Teenagers

In 2001, a study conducted by a leading drug manufacturer determined that the antidepressant Paxil was effective and safe for use by teenagers. After reexamining data from that study, another study was published last week and drew the opposite conclusion. After… Read More

New Study Claims Viagra Use May Increase Risk of Melanoma

The Phillips Law Group is investigating claims that Viagra (sildenafil) may lead to an increased risk of the melanoma type of skin cancer in men who have used the drug. A study of the erectile dysfunction medication was recently published in the Journal… Read More

FDA Calls for Label Changes on Blood Pressure Medication Benicar

The U.S. Food and Drug Administration (FDA) has completed a safety review of Benicar and other olmesartan drugs and has requested that drug manufacturers update the labels on these drugs. According to the FDA, the labels should include information about… Read More

Severe Side Effects Linked to Benicar

Benicar, a widely prescribed blood pressure medication, has been linked to several serious side effects including celiac disease-like symptoms, heart attacks, and death. The U.S. Food and Drug Administration (FDA) recently required Benicars manufacturer… Read More

Pradaxa Blood Thinner Lawsuits Settled for $650 Million

The German pharmaceutical company which developed and marketed Pradaxa has agreed to settle almost 4,000 lawsuits over the blood thinner for a total of $650 million dollars. Pradaxa is accused of causing over 500 deaths and more than 3,000 bleeding-related… Read More

Back to Top